Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
暂无分享,去创建一个
Issam El Naqa | Prajnan Das | Aditya Apte | C. Willett | I. El Naqa | W. Bosch | L. Kachnic | T. Hong | P. Das | A. Apte | R. Abrams | L. Gunderson | R. Myerson | M. Garofalo | Leonard L. Gunderson | Robert J. Myerson | Michael C. Garofalo | Ross A. Abrams | Walter R. Bosch | Theodore S. Hong | J.J. John Kim | Christopher G. Willett | Lisa A. Kachnic | J. Kim | T. Hong | R. Abrams | J.J. John Kim | Christopher G. Willett | Michael C. Garofalo | I. E. El Naqa | Theodore S. Hong | Ross A. Abrams | Walter R. Bosch | J.J. John Kim | P. Das
[1] E. Sigurdson,et al. Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. , 2007, International journal of radiation oncology, biology, physics.
[2] J. Tepper,et al. Risk of Pelvic Fractures in Older Women Following Pelvic Irradiation , 2005, Journal of the American Medical Association (JAMA).
[3] P. Bendahl,et al. Dose-volume relationships between enteritis and irradiated bowel volumes during 5-fluorouracil and oxaliplatin based chemoradiotherapy in locally advanced rectal cancer , 2007, Acta oncologica.
[4] M M Kligerman,et al. A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation. , 1986, International journal of radiation oncology, biology, physics.
[5] Peter Smeets,et al. Clinical implementation of intensity-modulated arc therapy (IMAT) for rectal cancer. , 2004, International journal of radiation oncology, biology, physics.
[6] Josef Korinek,et al. Proceedings of the American Society of Clinical Oncology , 1982 .
[7] A. Markoe,et al. Dose escalation in chemoradiation for anal cancer: preliminary results of RTOG 92-08. , 1996, The cancer journal from Scientific American.
[8] Charles R. Thomas,et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. , 2008, JAMA.
[9] R. Drzymala,et al. Technical aspects of image-based treatment planning of rectal carcinoma. , 2003, Seminars in radiation oncology.
[10] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.
[11] D. Yan,et al. The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. , 2002, International journal of radiation oncology, biology, physics.
[12] D. Dearnaley,et al. Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. , 2006, International journal of radiation oncology, biology, physics.
[13] Yi-Jen Chen,et al. Organ sparing by conformal avoidance intensity modulated radiation therapy for anal cancer: Dosimetric evaluation of coverage of pelvis and inguinal/femoral nodes , 2005 .
[14] Rainer Fietkau,et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. , 2004, The New England journal of medicine.
[15] Robert C. Frazier,et al. The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer , 2002 .
[16] L. Tho,et al. Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning. , 2006, International journal of radiation oncology, biology, physics.
[17] Karin Haustermans,et al. Definition and delineation of the clinical target volume for rectal cancer. , 2006, International journal of radiation oncology, biology, physics.
[18] J. Roeske,et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] S. Lipsitz,et al. Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study. , 1996, International journal of radiation oncology, biology, physics.
[20] N. Petrelli,et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] D. Yan,et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. , 2002, International journal of radiation oncology, biology, physics.
[22] C. Willett,et al. Randomized phase II trial of preoperative combined modality chemoradiation for distal rectal cancer , 2004 .
[23] P. Parikh,et al. Two-year outcomes of RTOG 0529: A phase II evaluation of dose-painted IMRT in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] C. Lemanski,et al. Optimal organ-sparing intensity-modulated radiation therapy (IMRT) regimen for the treatment of locally advanced anal canal carcinoma: a comparison of conventional and IMRT plans , 2007, Radiation oncology.
[25] Bernard Leduc,et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] W. Grove. Statistical Methods for Rates and Proportions, 2nd ed , 1981 .
[27] William M. Wells,et al. Simultaneous truth and performance level estimation (STAPLE): an algorithm for the validation of image segmentation , 2004, IEEE Transactions on Medical Imaging.
[28] B. Everitt,et al. Statistical methods for rates and proportions , 1973 .
[29] Laurence Collette,et al. Chemotherapy with preoperative radiotherapy in rectal cancer. , 2006, The New England journal of medicine.
[30] Ashesh B Jani,et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. , 2005, International journal of radiation oncology, biology, physics.
[31] Tae Hyun Kim,et al. Intensity-modulated radiotherapy with a belly board for rectal cancer , 2007, International Journal of Colorectal Disease.
[32] D. Yan,et al. The influence of small bowel motion on both a conventional three-field and intensity modulated radiation therapy (IMRT) for rectal cancer. , 2004, Cancer Radiothérapie.